Literature DB >> 17311869

Early treatment with hydroxyethyl starch 130/0.4 causes greater inhibition of pulmonary capillary leakage and inflammatory response than treatment instituted later in sepsis induced by cecal ligation and puncture in rats.

Xiaomei Feng1, Yimin Hu, Jingjing Ding, Yali Ge, Juan Song, Qing Ai, Zhijie Zhang, Jianguo Xu.   

Abstract

This study investigated the temporal profile of effects of hydroxyethyl starch (HES) 130/0.4 on pulmonary capillary leakage in a rat sepsis model induced by cecal ligation and puncture (CLP). Arterial blood pressure and heart rate were monitored during the experiment. Pulmonary capillary leakage was evaluated at 6, 12, 18, and 24 hr after CLP, and HES 130/0.4 was infused iv 2 hr prior to each time point. Myeloperoxidase (MPO) activity of lung homogenates and pulmonary levels of tumor necrosis factor alpha (TNF-alpha), interleukin (IL)-6, IL-10, and nuclear factor-kappaB (NF-kappaB) activity were measured. Infusion of HES 130/0.4 attenuated the pulmonary capillary leakage, reduced the elevations of MPO, TNF-alpha, IL-6, and NF-kappaB levels, and further increased the IL-10 level. Infusion of HES 130/0.4 at 4 or 10 hr after the septic insult resulted in the greatest decreases in inflammatory mediators, suggesting that HES 130/0.4 is more protective against pulmonary capillary leakage when given early rather than later during sepsis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17311869

Source DB:  PubMed          Journal:  Ann Clin Lab Sci        ISSN: 0091-7370            Impact factor:   1.256


  4 in total

Review 1.  Controversies in fluid therapy: Type, dose and toxicity.

Authors:  Robert C McDermid; Karthik Raghunathan; Adam Romanovsky; Andrew D Shaw; Sean M Bagshaw
Journal:  World J Crit Care Med       Date:  2014-02-04

2.  Hydroxyethyl starch (HES 130/0.4) impairs intestinal barrier integrity and metabolic function: findings from a mouse model of the isolated perfused small intestine.

Authors:  Yuk Lung Wong; Ingmar Lautenschläger; Heike Dombrowsky; Karina Zitta; Berthold Bein; Thorsten Krause; Torsten Goldmann; Inez Frerichs; Markus Steinfath; Norbert Weiler; Martin Albrecht
Journal:  PLoS One       Date:  2015-03-23       Impact factor: 3.240

3.  Adverse effects of hydroxyethyl starch (HES 130/0.4) on intestinal barrier integrity and metabolic function are abrogated by supplementation with Albumin.

Authors:  Yuk Lung Wong; Ingmar Lautenschläger; Karina Zitta; Christin Schildhauer; Kerstin Parczany; Christoph Röcken; Markus Steinfath; Norbert Weiler; Martin Albrecht
Journal:  J Transl Med       Date:  2016-02-27       Impact factor: 5.531

Review 4.  Sources of Heterogeneity in Trials Reporting Hydroxyethyl Starch 130/0.4 or 0.42 Associated Excess Mortality in Septic Patients: A Systematic Review and Meta-regression.

Authors:  Peng-Lin Ma; Xiao-Xia Peng; Bin Du; Xiao-Lan Hu; Yi-Chun Gong; Yu Wang; Xiu-Ming Xi
Journal:  Chin Med J (Engl)       Date:  2015-09-05       Impact factor: 2.628

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.